hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06343649, orgStudyIdInfo id: CEUMA 187-2023-H, briefTitle: Explicit Motor Imagery in Persistent Pelvic Pain, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-11-01, primaryCompletionDateStruct date: 2023-11-30, completionDateStruct date: 2023-11-30, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-23, sponsorCollaboratorsModule leadSponsor name: University of Valencia, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to compare the response of Explicit Motor Imagery interventions in patients suffering Persistent Pelvic Pain. The main question it aims to answer is:• Does the modality of application of Explicit Motor Imagery, either through visual or auditory stimuli, influence the response in patients suffering Persistent Pelvic Pain?Participants will receive an online Explicit Motor Imagery program either through visual inputs or auditory inputs. They will be instructed to follow the program en register their response.Researchers will compare visual Explicit Motor Imagery and auditory Explicit Motor Imagery to see if different inputs generate different responses in patients suffering Persistent Pelvic Pain., conditionsModule conditions: Pelvic Pain, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 49, type: ACTUAL, armsInterventionsModule interventions name: Visual, interventions name: Auditory, outcomesModule primaryOutcomes measure: Numerical Rating Scale, primaryOutcomes measure: Pain Vigilance and Awareness Questionnaire, secondaryOutcomes measure: Movement Imagery Questionnaire-Revised, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Valencia, city: Valencia, zip: 46010, country: Spain, geoPoint lat: 39.46975, lon: -0.37739, hasResults: False
protocolSection identificationModule nctId: NCT06343636, orgStudyIdInfo id: VG3927-02.101, briefTitle: A Phase 1 Study of VG-3927 in Healthy Adults, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2023-09-27, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Vigil Neuroscience, Inc., class: INDUSTRY, descriptionModule briefSummary: A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VG-3927 in Healthy Adults, conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: SEQUENTIAL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 90, type: ESTIMATED, armsInterventionsModule interventions name: VG-3927, interventions name: Placebo, outcomesModule primaryOutcomes measure: Adverse Events, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 55 Years, stdAges: ADULT, contactsLocationsModule locations facility: Clinical Pharmacology of Miami, city: Miami, state: Florida, zip: 33014, country: United States, geoPoint lat: 25.77427, lon: -80.19366, hasResults: False
protocolSection identificationModule nctId: NCT06343623, orgStudyIdInfo id: fac.med.2018.15, briefTitle: Superiorly Based Pharyngeal Flap Versus Myomucosal Resection and Direct Closure, statusModule overallStatus: COMPLETED, startDateStruct date: 2018-10-12, primaryCompletionDateStruct date: 2022-10-16, completionDateStruct date: 2022-10-16, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Minia University, class: OTHER, descriptionModule briefSummary: Patients were classified into two groups. Group (A) patients included fifty patients had velopharyngeal insufficiency and were surgically corrected by the superiorly based pharyngeal flap. Group (B) patients included fifty patients had velopharyngeal insufficiency and were surgically corrected with myomucosal resection and direct closure of the posterior pharyngeal wall, conditionsModule conditions: Velopharyngeal Insufficiency, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 150, type: ACTUAL, armsInterventionsModule interventions name: myomucosal resection and direct closure, interventions name: superiorly based flap, outcomesModule primaryOutcomes measure: Improvement in the speech outcome, secondaryOutcomes measure: obstructive sleep apnea, eligibilityModule sex: ALL, minimumAge: 4 Years, maximumAge: 10 Years, stdAges: CHILD, contactsLocationsModule locations facility: Faculty of medicine, city: Minya, zip: 61511, country: Egypt, geoPoint lat: 28.10988, lon: 30.7503, hasResults: False
protocolSection identificationModule nctId: NCT06343610, orgStudyIdInfo id: VIST TO-UV 01-2024, briefTitle: The Effect of 8-week Dietary Intake of Novel Food Supplement on Minimal Erythema Dose, acronym: VIST-TO-UV, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2024-07, completionDateStruct date: 2024-10, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: VIST - Faculty of Applied Sciences, class: OTHER, descriptionModule briefSummary: This is a double-blind, randomized, placebo-controlled interventional study of the effect of multiple-dose dietary intake on minimal erythema dose and other skin parameters., conditionsModule conditions: Minimal Erythema Dose, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 54, type: ESTIMATED, armsInterventionsModule interventions name: Active product, interventions name: Placebo, outcomesModule primaryOutcomes measure: Change of minimal erythema dose, secondaryOutcomes measure: Change of redness formation, eligibilityModule sex: ALL, minimumAge: 21 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: VIST - Faculty of Applied Sciences, Institute of Cosmetics, status: RECRUITING, city: Ljubljana, zip: 1000, country: Slovenia, contacts name: Katja Zmitek, PhD, role: CONTACT, phone: 002831700, email: katja.zmitek@vist.si, contacts name: Katja Žmitek, PhD, role: PRINCIPAL_INVESTIGATOR, contacts name: Tina Pogačnik, MSc, role: SUB_INVESTIGATOR, contacts name: Petra Keršmanc, MSc, role: SUB_INVESTIGATOR, contacts name: Sara Jereb, Msc, role: SUB_INVESTIGATOR, geoPoint lat: 46.05108, lon: 14.50513, hasResults: False
protocolSection identificationModule nctId: NCT06343597, orgStudyIdInfo id: 037.HPB.2020.R, briefTitle: Volume Outcome Relationships and Effects, statusModule overallStatus: RECRUITING, startDateStruct date: 2020-06-15, primaryCompletionDateStruct date: 2025-06-15, completionDateStruct date: 2025-06-15, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Methodist Health System, class: OTHER, descriptionModule briefSummary: This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities., conditionsModule conditions: Esophageal Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 30, type: ESTIMATED, outcomesModule primaryOutcomes measure: Esophageal Cancer resection in patients in high volume (more than 5 esophagectomy performed per year) and low volume (less than 5 esophagectomy performed per year) hospital facilities, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Methodist Richardson Medical Center, status: RECRUITING, city: Richardson, state: Texas, zip: 75082, country: United States, contacts name: Crystee Cooper, DHEd, role: CONTACT, phone: 214-947-1280, email: clinicalresearch@mhd.com, contacts name: Zaid Haddadin, MS, role: CONTACT, phone: 2149471280, email: clinicalresearch@mhd.com, contacts name: Dhiresh Jeyarajah, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 32.94818, lon: -96.72972, hasResults: False
protocolSection identificationModule nctId: NCT06343584, orgStudyIdInfo id: 023.NUR.2021.M, briefTitle: Are Personal Smartphones Hurting Work-Life Balance for Nurse Managers?, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-07-01, primaryCompletionDateStruct date: 2022-05-06, completionDateStruct date: 2022-05-06, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Methodist Health System, class: OTHER, descriptionModule briefSummary: For leadership positions with only a handful of staff under their direct chain of command, this may not be all-consuming and detrimental to work-life balance. But for NMs with upwards of 100 direct reports, this can make for a never-ending stream of contact points. This study will implement several communication and behavioral strategies to determine how using provided smartphone tools impact work-life balance and professional burnout., conditionsModule conditions: Burnout, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 6, type: ACTUAL, armsInterventionsModule interventions name: Study will conducted over a six-month period using a quasi-experimental Pre-test/Post-test design using Stamm's (2009) ProQOL Scale., outcomesModule primaryOutcomes measure: • Impact of smartphone tool utilization will be measured using a pre-study survey and post-study survey using the Professional Quality of Life (ProQOL) Scale (Stamm, 2009)., secondaryOutcomes measure: • Participants in Group 1 will self-report on the post-study survey (Appendix D1) the number of tools implemented during the study duration., secondaryOutcomes measure: • Participants in Group 1 will self-report on the post-study survey (Appendix D1) the frequency of tool utilization during the study duration using a Likert scale., secondaryOutcomes measure: • Participants in Group 2 will self-report on the post-study survey (Appendix D2) using the ProQOL Scale., secondaryOutcomes measure: • Responses to the post-study survey from participants in Group 2 will be compared to participants in Group 1 to determine if utilizing a separate work smartphone during business hours has a greater improvement on work-life balance and burnout., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Methodist Mansfield Medical Center, city: Mansfield, state: Texas, zip: 76063, country: United States, geoPoint lat: 32.56319, lon: -97.14168, hasResults: False
protocolSection identificationModule nctId: NCT06343571, orgStudyIdInfo id: MED-EL_CRD_2022_12, briefTitle: Longitudinal Outcomes in MED-EL Cochlear Implant Recipients Using a FLEX Electrode, acronym: LOTOS, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2024-08, completionDateStruct date: 2024-08, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: MED-EL Elektromedizinische Geräte GesmbH, class: INDUSTRY, descriptionModule briefSummary: This retrospective study aims at analysing data from clinical routine as anonymized data sets. The study aims at analysing clinical data from MED-EL Cochlear Implant (CI) recipients using a FLEX electrode array., conditionsModule conditions: Cochlear Implants, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 2000, type: ESTIMATED, outcomesModule primaryOutcomes measure: Evaluate short and long term longitudinal clinical performance data from MED-EL CIs to assess their clinical effectiveness and safety., eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06343545, orgStudyIdInfo id: Rehab_PROADI, briefTitle: Evaluation of the Impact of Rehabilitation Strategies and Early Discharge After Respiratory Failure, acronym: Rehab, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2026-07-30, completionDateStruct date: 2026-12-31, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Hospital Israelita Albert Einstein, class: OTHER, descriptionModule briefSummary: To evaluate, through a randomized clinical trial in groups/clusters (stepped wedge), the impact of specific bundles for disability prevention and early rehabilitation, focused on 3 domains (ICU, Ward and post-discharge), on health-related quality of life and other long- and short-term outcomes in critically ill patients affected by hypoxemic acute respiratory failure with suspected COVID-19., conditionsModule conditions: Acute Respiratory Failure, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: Cluster crossover randomized trial, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 2000, type: ESTIMATED, armsInterventionsModule interventions name: Standard of Care, interventions name: Rehabilitation, outcomesModule primaryOutcomes measure: Quality of life, secondaryOutcomes measure: Mortality, secondaryOutcomes measure: Days alive and free of hospital, secondaryOutcomes measure: Rehospitalization, secondaryOutcomes measure: Return to work, secondaryOutcomes measure: Anxiety and Depression, secondaryOutcomes measure: New disability, secondaryOutcomes measure: Disability, secondaryOutcomes measure: Clinical Status, secondaryOutcomes measure: Cognitive impairment, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06343532, orgStudyIdInfo id: NIDA-SXC-Ph1b-001, briefTitle: SXC-2023 Cocaine Interaction Study, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: National Institute on Drug Abuse (NIDA), class: NIH, collaborators name: Promentis Pharmaceuticals, Inc., collaborators name: Altasciences Company Inc., collaborators name: Technical Resources International, Inc., descriptionModule briefSummary: The goal of this clinical trial is to determine whether there are any interactions between the study drug and cocaine. Researchers will compare a treatment group and a placebo group to see if they experience any effects when administered cocaine after taking the treatment/placebo., conditionsModule conditions: Cocaine Use Disorder, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: SXC-2023, interventions name: SXC-2023 Placebo, outcomesModule primaryOutcomes measure: Determine Safety and Tolerability of Oral SXC-2023 Co-administered with Intravenous Cocaine by Collecting Vital Signs and Adverse Events, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 59 Years, stdAges: ADULT, contactsLocationsModule locations facility: Altasciences Clinical Kansas, Inc., city: Overland Park, state: Kansas, zip: 66212, country: United States, contacts name: Debra J Kelsh, MD, role: CONTACT, phone: 913-696-1601, email: DKelsh@altasciences.com, contacts name: Debra J Kelsh, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 38.98223, lon: -94.67079, hasResults: False
protocolSection identificationModule nctId: NCT06343519, orgStudyIdInfo id: Shocked Patients Monitoring, briefTitle: Echocardiographic and Laboratory Findings in Hemodynamic Monitoring of Shocked Patients, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2026-03, completionDateStruct date: 2026-05, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: Shocked patients require prompt and accurate assessment of their hemodynamic status to guide appropriate management. Echocardiography is a valuable tool for assessing cardiac function, while laboratory parameters such as mixed venous oxygen saturation and arterial blood lactate provide insights into tissue perfusion and oxygen metabolism. This study aims to compare echocardiographic findings, including cardiac index, speckle tracking parameters, and tissue Doppler indices, with laboratory findings in the evaluation of hemodynamic monitoring in shocked patients., conditionsModule conditions: Shock, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Echocardiography, outcomesModule primaryOutcomes measure: Change in Shock Status After Fluid Therapy Based on Echocardiographic Assessment of Fluid Responsiveness, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06343506, orgStudyIdInfo id: 2023-929-EXPEDITED, briefTitle: Ankle Dorsiflexion Changes With Assisted Stretching Device, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-10-30, primaryCompletionDateStruct date: 2024-06-01, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-04, sponsorCollaboratorsModule leadSponsor name: Montana State University, class: OTHER, descriptionModule briefSummary: Ankle range of motion is an important degree of freedom for performing activities of daily living. Limited range of ankle motion has been related to Achilles tendonitis, lower limb injury, and abnormal gait leading to overuse injury. While stretching and massage can help increase range of motion the amount and frequency of manual manipulation needed to affect range of motion is not accessible to an individual in their home. A new device has been developed to allow deep stretching of the ankle and surrounding muscles to help increase ankle dorsiflexion. This device can be used in an individual's home, without assistance, allowing more frequent stretching without increased visits to physical therapy. The goal of this study is to determine the effect of using this device during a course of treatment to improve ankle dorsiflexion in individuals with decreased ankle range of motion., conditionsModule conditions: Physical Therapy Modality, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: Grassroots Ankle Flex, outcomesModule primaryOutcomes measure: Ankle Range of Motion, secondaryOutcomes measure: Ankle Strength, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Neuromuscular Biomechanics Laboratory, status: RECRUITING, city: Bozeman, state: Montana, zip: 59717, country: United States, contacts name: Corey Pew, PhD, role: CONTACT, phone: 406-994-6769, email: Corey.Pew@montana.edu, geoPoint lat: 45.67965, lon: -111.03856, hasResults: False
protocolSection identificationModule nctId: NCT06343493, orgStudyIdInfo id: JALTAF, briefTitle: Effect of Hot Saline Irrigation on the Operative Field During Endoscopic Sinus Surgery, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-06-16, primaryCompletionDateStruct date: 2023-12-15, completionDateStruct date: 2023-12-31, studyFirstPostDateStruct date: 2024-04-02, lastUpdatePostDateStruct date: 2024-04-02, sponsorCollaboratorsModule leadSponsor name: Rawalpindi Medical College, class: OTHER, descriptionModule briefSummary: Control of bleeding is very important during endoscopic sinus surgery. Saline heated up to 50°C causes dilatation of vessels and edema without nasal mucosa necrosis. It also promotes the clotting cascade so helps in having a bloodless procedure.This randomized controlled trial was conducted on 60 patients divided into two groups (30 each). Group A was the interventional group in which patients were irrigated with saline of 50°C during surgery. Group B was the control group where room temperature saline was used. Operative field was assessed using the Boezaart score, duration of surgery and bleeding in ml.KEY WORDS:* Chronic rhinosinusitis (CRS)* Endoscopic sinus surgery* Boezaart score, conditionsModule conditions: Rhinosinusitis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: Normal saline heated up to 50 °C, outcomesModule primaryOutcomes measure: Boezaart Score, secondaryOutcomes measure: Bleeding in ml, secondaryOutcomes measure: Duration of Surgery, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Benazir Bhutto Hospital, city: Rawalpindi, state: Punjab, zip: 46000, country: Pakistan, geoPoint lat: 33.6007, lon: 73.0679, documentSection largeDocumentModule largeDocs typeAbbrev: Prot_SAP, hasProtocol: True, hasSap: True, hasIcf: False, label: Study Protocol and Statistical Analysis Plan, date: 2023-05-16, uploadDate: 2024-03-29T12:12, filename: Prot_SAP_000.pdf, size: 142077, largeDocs typeAbbrev: ICF, hasProtocol: False, hasSap: False, hasIcf: True, label: Informed Consent Form, date: 2023-06-16, uploadDate: 2024-03-24T04:58, filename: ICF_001.pdf, size: 48384, hasResults: False